# Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

> **NCT00949117** · PHASE2 · TERMINATED · sponsor: **University of South Florida** · enrollment: 9 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Malnutrition
- Myelodysplastic Syndromes
- Unspecified Childhood Solid Tumor, Protocol Specific
- Weight Changes

## Interventions

- **DIETARY_SUPPLEMENT:** Ensure
- **DIETARY_SUPPLEMENT:** PediaSure
- **DRUG:** cyproheptadine hydrochloride

## Key facts

- **NCT ID:** NCT00949117
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** study not feasible with low accrual. DSMB recommended closure
- **Last updated:** 2014-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949117, "Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00949117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*